Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 1, 2012, Pages

  Marron, Thomas U ^a   Martinez Gallo, Monica ^a,b   Yu, Joyce E ^a,c   Cunningham Rundles, Charlotte ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Bruton tyrosine kinase; MyD88 adapter like protein; Toll IL 1 receptor domain containing adapter protein; Toll like receptors; X linked agammaglobulinemia

Indexed keywords

ALPHA INTERFERON; BRUTON TYROSINE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MONOCYTE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; X LINKED AGAMMAGLOBULINEMIA;

EID: 84455205579     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.10.009     Document Type: Article

References (55)

1. E.J. Hennessy, A.E. Parker, and L.A. O'Neill Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9 2010 293 307
2. A.M. Avalos, L. Busconi, and A. Marshak-Rothstein Regulation of autoreactive B cell responses to endogenous TLR ligands Autoimmunity 43 2009 76 83
3. P. Pisitkun, J.A. Deane, M.J. Difilippantonio, T. Tarasenko, A.B. Satterthwaite, and S. Bolland Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication Science 312 2006 1669 1672
4. J.M. Reynolds, B.P. Pappu, J. Peng, G.J. Martinez, Y. Zhang, and Y. Chung Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease Immunity 32 2010 692 702
5. F.M. Uckun, and S. Qazi Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity Expert Opin Ther Pat 20 2010 1457 1470
6. S.L. Doyle, C.A. Jefferies, C. Feighery, and L.A. O'Neill Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase J Biol Chem 282 2007 36953 36960
7. S.L. Doyle, C.A. Jefferies, and L.A. O'Neill Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide J Biol Chem 280 2005 23496 23501
8. M. Hasan, G. Lopez-Herrera, K.E. Blomberg, J.M. Lindvall, A. Berglof, and C.I. Smith Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice Immunology 123 2008 239 249
9. N.J. Horwood, T. Mahon, J.P. McDaid, J. Campbell, H. Mano, and F.M. Brennan Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production J Exp Med 197 2003 1603 1611
10. N.J. Horwood, T.H. Page, J.P. McDaid, C.D. Palmer, J. Campbell, and T. Mahon Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production J Immunol 176 2006 3635 3641
11. C.A. Jefferies, S. Doyle, C. Brunner, A. Dunne, E. Brint, and C. Wietek Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4 J Biol Chem 278 2003 26258 26264
12. K.G. Lee, S. Xu, E.T. Wong, V. Tergaonkar, and K.P. Lam Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells J Biol Chem 283 2008 11189 11198
13. M. Liljeroos, R. Vuolteenaho, S. Morath, T. Hartung, M. Hallman, and M. Ojaniemi Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages Cell Signal 19 2007 625 633
14. A. Mangla, A. Khare, V. Vineeth, N.N. Panday, A. Mukhopadhyay, and B. Ravindran Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses Blood 104 2004 1191 1197
15. N.W. Schmidt, V.T. Thieu, B.A. Mann, A.N. Ahyi, and M.H. Kaplan Bruton's tyrosine kinase is required for TLR-induced IL-10 production J Immunol 177 2006 7203 7210
16. K. Sochorova, R. Horvath, D. Rozkova, J. Litzman, J. Bartunkova, and A. Sediva Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia Blood 109 2007 2553 2556
17. H. Taneichi, H. Kanegane, M.M. Sira, T. Futatani, K. Agematsu, and M. Sako Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia Clin Immunol 126 2008 148 154
18. S. Tsukada, D.C. Saffran, D.J. Rawlings, O. Parolini, R.C. Allen, and I. Klisak Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia Cell 72 1993 279 290
19. J.M. Lindvall, K.E. Blomberg, J. Valiaho, L. Vargas, J.E. Heinonen, and A. Berglof Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling Immunol Rev 203 2005 200 215
20. M. Vihinen, D. Vetrie, H.S. Maniar, H.D. Ochs, Q. Zhu, and I. Vorechovsky Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease Proc Natl Acad Sci U S A 91 1994 12803 12807
21. M.E. Conley Genetics of hypogammaglobulinemia: what do we really know? Curr Opin Immunol 21 2009 466 471
22. J.A. Winkelstein, M.E. Conley, C. James, V. Howard, and J. Boyle Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes Medicine (Baltimore) 87 2008 253 258
23. J.A. Winkelstein, M.C. Marino, H.M. Lederman, S.M. Jones, K. Sullivan, and A.W. Burks X-linked agammaglobulinemia: report on a United States registry of 201 patients Medicine (Baltimore) 85 2006 193 202
24. M.E. Conley B cells in patients with X-linked agammaglobulinemia J Immunol 134 1985 3070 3074
25. W. Ellmeier, S. Jung, M.J. Sunshine, F. Hatam, Y. Xu, and D. Baltimore Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk J Exp Med 192 2000 1611 1624
26. D.J. Rawlings, D.C. Saffran, S. Tsukada, D.A. Largaespada, J.C. Grimaldi, and L. Cohen Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice Science 261 1993 358 361
27. R. Perez de Diego, E. Lopez-Granados, M. Pozo, C. Rodriguez, P. Sabina, and A. Ferreira Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes J Allergy Clin Immunol 117 2006 1462 1469
28. H. Jyonouchi, L. Geng, G.A. Toruner, K. Vinekar, D. Feng, and P. Fitzgerald-Bocarsly Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses Eur J Pediatr 167 2008 317 321
29. P. Gray, A. Dunne, C. Brikos, C.A. Jefferies, S.L. Doyle, and L.A. O'Neill MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction J Biol Chem 281 2006 10489 10495
30. L.A. Honigberg, A.M. Smith, M. Sirisawad, E. Verner, D. Loury, and B. Chang The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy Proc Natl Acad Sci U S A 107 2010 13075 13080
31. J.A. Di Paolo, T. Huang, M. Balazs, J. Barbosa, K.H. Barck, and B.J. Bravo Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis Nat Chem Biol 7 2011 41 50
32. C. Cunningham-Rundles, and L. Radigan Deficient IL-12 and dendritic cell function in common variable immune deficiency Clin Immunol 115 2005 147 153
33. T.U. Marron, K. Rohr, M. Martinez-Gallo, J. Yu, and C. Cunningham-Rundles TLR signaling and effector functions are intact in XLA neutrophils Clin Immunol 137 2010 74 80
34. C. Cunningham-Rundles, L. Radigan, A.K. Knight, L. Zhang, L. Bauer, and A. Nakazawa TLR9 activation is defective in common variable immune deficiency J Immunol 176 2006 1978 1987
35. A. Mansell, R. Smith, S.L. Doyle, P. Gray, J.E. Fenner, and P.J. Crack Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation Nat Immunol 7 2006 148 155
36. C.N. Zorn, S. Keck, R.W. Hendriks, M. Leitges, M.A. Freudenberg, and M. Huber Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells Cell Signal 21 2009 79 86
37. M.C. Gagliardi, A. Finocchi, P. Orlandi, L. Cursi, C. Cancrini, and V. Moschese Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function Clin Exp Immunol 133 2003 115 122
38. J. Bayry, S. Lacroix-Desmazes, V. Donkova-Petrini, C. Carbonneil, N. Misra, and Y. Lepelletier Natural antibodies sustain differentiation and maturation of human dendritic cells Proc Natl Acad Sci U S A 101 2004 14210 14215
39. C. Gilbert, S. Levasseur, P. Desaulniers, A.A. Dusseault, N. Thibault, and S.G. Bourgoin Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor J Immunol 170 2003 5235 5243
40. T. Matsuda, M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, and S. Tsukada Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines Blood 85 1995 627 633
41. N.F. Go, B.E. Castle, R. Barrett, R. Kastelein, W. Dang, and T.R. Mosmann Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells J Exp Med 172 1990 1625 1631
42. E. van den Akker, T.B. van Dijk, U. Schmidt, L. Felida, H. Beug, and B. Lowenberg The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity Biol Chem 385 2004 409 413
43. K.A. Fitzgerald, E.M. Palsson-McDermott, A.G. Bowie, C.A. Jefferies, A.S. Mansell, and G. Brady Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction Nature 413 2001 78 83
44. A. Dunne, S. Carpenter, C. Brikos, P. Gray, A. Strelow, and H. Wesche IRAK1 and IRAK4 promote phosphorylation, ubiquitination and degradation of MyD88 adapter-like (MAL) J Biol Chem 285 2010 18276 18282
45. T.C. Islam, J. Lindvall, A. Wennborg, L.J. Branden, H. Rabbani, and C.I. Smith Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays Eur J Immunol 32 2002 982 993
46. J.E. Yu, A.K. Knight, L. Radigan, T.U. Marron, L. Zhang, and S. Sanchez-Ramon Toll-like receptor 7 and 9 defects in common variable immunodeficiency J Allergy Clin Immunol 124 2009 349 356 e1-3
47. L. Danks, S. Workman, D. Webster, and N.J. Horwood Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts J Bone Miner Res 26 2011 182 192
48. V. Howard, J.M. Greene, S. Pahwa, J.A. Winkelstein, J.M. Boyle, and M. Kocak The health status and quality of life of adults with X-linked agammaglobulinemia Clin Immunol 118 2006 201 208
49. C.M. Roifman, C.P. Rao, H.M. Lederman, S. Lavi, P. Quinn, and E.W. Gelfand Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia Am J Med 80 1986 590 594
50. M. Stuckey, P.A. Quinn, and E.W. Gelfand Identification of Ureaplasma urealyticum (T-strain Mycoplasma) in patient with polyarthritis Lancet 2 1978 917 920
51. S. Sukumaran, K. Marzan, B. Shaham, and J.A. church A child with X-linked agammaglobulinemia and enthesitis-related arthritis Int J Rheumatol 2011 2011 175973
52. G. Verbruggen, S. De Backer, D. Deforce, P. Demetter, C. Cuvelier, and E. Veys X linked agammaglobulinaemia and rheumatoid arthritis Ann Rheum Dis 64 2005 1075 1078
53. A.D. Webster, G. Loewi, R.D. Dourmashkin, D.N. Golding, D.J. Ward, and G.L. Asherson Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment BMJ 1 1976 1314 1316
54. P.R. Murray, A. Jain, G. Uzel, R. Ranken, C. Ivy, and L.B. Blyn Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis Arch Dermatol 146 2010 523 526
55. P.L. Quan, T.A. Wagner, T. Briese, T.R. Torgerson, M. Hornig, and A. Tashmukhamedova Astrovirus encephalitis in boy with X-linked agammaglobulinemia Emerg Infect Dis 16 2010 918 925